ESBL-producing Enterobacteriaceae in Africa - a non-systematic literature review of research published 2008-2012

Infection Ecology and Epidemiology

Volumn 4, Issue 1, 2014, Pages

  Storberg, Viktor ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Africa; Antibiotic resistance; Community; Enterobacteriaceae; Extended spectrum beta lactamases; Hospital

Indexed keywords

BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CARBAPENEMASE;

AFRICA; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENE IDENTIFICATION; HUMAN; MICROBIAL COMMUNITY; NONHUMAN; PREVALENCE; REVIEW; SPECIES DISTRIBUTION;

EID: 85017282251     PISSN: None     EISSN: 20008686     Source Type: Journal    
DOI: 10.3402/iee.v4.20342     Document Type: Review

References (80)

1. Colodner R, Raz R. Extended-spectrum beta-lactamases: the end of cephalosporins? Isr Med Assoc J 2005; 7: 336-8.
2. Jaggi N, Sissodia P, Sharma L. Control of multidrug resistant bacteria in a tertiary care hospital in India. Antimicrob Resist Infect Control 2012; 1: 23.
3. Kanafani ZA, Mehio-Sibai A, Araj GF, Kanaan M, Kanj SS. Epidemiology and risk factors for extended-spectrum betalactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 2005; 33: 326-32.
4. Marcel JP, Alfa M, Baquero F, Etienne J, Goossens H, Harbarth S, et al. Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect 2008; 14: 895-907.
5. Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-8.
6. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008; 14(Suppl 1): 144-53.
7. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008; 13(47): 1-11.
8. Bush K. Extended-spectrum beta-lactamases in North America, 1987-2006. Clin Microbiol Infect 2008; 14(Suppl 1): 134-43.
9. Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents 2011; 37: 291-5.
10. ECDC (2008). EARSS annual report 2008. Bilthoven, the Netherlands: European Center for Disease Prevention and Control.
11. Hoban DJ, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, et al. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extendedspectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010. Diagn Microbiol Infect Dis 2012; 74: 62-7.
12. Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, et al. Epidemiology and antimicrobial susceptibility profiles of Gramnegative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 2012; 40(Suppl): S37-43.
13. Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN. Prevalence and significance of a negative extendedspectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program. J Clin Microbiol 2007; 45: 1478-82.
14. Hedin A, Källestå L C. Knowledge-based public health work Part 2. Stockholm: National Institute of Public Health; 2004.
15. United Nations (2011). Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. Available from: http://unstats. un.org/unsd/methods/m49/m49regin.htm [cited 1 October 2012].
16. Iabadene H, Messai Y, Ammari H, Alouache S, Verdet C, Bakour R, et al. Prevalence of plasmid-mediated AmpC betalactamases among Enterobacteriaceae in Algiers hospitals. Int J Antimicrob Agents 2009; 34: 340-2.
17. Iabadene H, Messai Y, Ammari H, Ramdani-Bouguessa N, Lounes S, Bakour R, et al. Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother 2008; 62: 133-6.
18. Messai Y, Iabadene H, Benhassine T, Alouache S, Tazir M, Gautier V, et al. Prevalence and characterization of extendedspectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol Biol (Paris) 2008; 56: 319-25.
19. Naas T, Bentchouala C, Cuzon G, Yaou S, Lezzar A, Smati F, et al. Outbreak of Salmonella enterica serotype Infantis producing ArmA 16S RNA methylase and CTX-M-15 extendedspectrum beta-lactamase in a neonatology ward in Constantine, Algeria. Int J Antimicrob Agents 2011; 38: 135-9.
20. Naas T, Bentchouala C, Lima S, Lezzar A, Smati F, Scheftel JM, et al. Plasmid-mediated 16S rRNA methylases among extended-spectrum-beta-lactamase-producing Salmonella enterica Senftenberg isolates from Algeria. J Antimicrob Chemother 2009; 64: 866-8.
21. Nedjai S, Barguigua A, Djahmi N, Jamali L, Zerouali K, Dekhil M, et al. Prevalence and characterization of extended spectrum beta-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria. Med Mal Infect 2012; 42: 20-9.
22. Ramdani-Bouguessa N, Manageiro V, Jones-Dias D, Ferreira E, Tazir M, Canica M. Role of SHV beta-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to betalactams in an Algerian hospital. J Med Microbiol 2011; 60: 983-7.
23. Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, et al. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist 2011; 17: 67-73.
24. Hassan WM, Hashim A, Domany R. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt. Indian J Med Microbiol 2012; 30: 442-7.
25. Khalaf NG, Eletreby MM, Hanson ND. Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect Dis 2009; 9: 84.
26. Isendahl J, Turlej-Rogacka A, Manjuba C, Rodrigues A, Giske CG, Naucler P. Fecal carriage of ESBL-producing E. coli and K. pneumoniae in children in Guinea-Bissau: a hospital-based cross-sectional study. PLoS One 2012; 7: e51981.
27. Pirs M, Andlovic A, Cerar T, Zohar-Cretnik T, Kobola L, Kolman J, et al. A case of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a patient transferred to Slovenia from Libya, November. Euro Surveill 2011; 16: 20042.
28. Bouchakour M, Zerouali K, Gros Claude JD, Amarouch H, El Mdaghri N, Courvalin P, et al. Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing Enterobacteriaceae in Morocco. J Infect Dev Ctries 2010; 4: 779-803.
29. Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother 2011; 66: 2781-3.
30. Villa L, Poirel L, Nordmann P, Carta C, Carattoli A. Complete sequencing of an IncH plasmid carrying the blaNDM-1, blaCTX-M-15 and qnrB1 genes. J Antimicrob Chemother 2012; 67: 1645-50.
31. Barguigua A, El Otmani F, Talmi M, Bourjilat F, Haouzane F, Zerouali K, et al. Characterization of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J Med Microbiol 2011; 60: 1344-52.
32. Barguigua A, El Otmani F, Talmi M, Reguig A, Jamali L, Zerouali K, et al. Prevalence and genotypic analysis of plasmidmediated beta-lactamases among urinary Klebsiella pneumoniae isolates in Moroccan community. J Antibiot (Tokyo) 2013; 66: 11-16.
33. Bourjilat F, Bouchrif B, Dersi N, Claude JD, Amarouch H, TiminouniM. Emergence of extended-spectrum beta-lactamasesproducing Escherichia coli in community-acquired urinary infections in Casablanca, Morocco. J Infect Dev Ctries 2011; 5: 850-5.
34. Abbassi MS, Torres C, Achour W, Vinue L, Saenz Y, Costa D, et al. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia. Int J Antimicrob Agents 2008; 32: 308-14.
35. Ben Achour N, Mercuri PS, Ben Moussa M, Galleni M, Belhadj O. Characterization of a novel extended-spectrum TEM-type beta-lactamase, TEM-164, in a clinical strain of Klebsiella pneumoniae in Tunisia. Microb Drug Resist 2009; 15: 195-9.
36. Ben Achour N, Mercuri PS, Power P, Belhadj C, Ben Moussa M, Galleni M, et al. First detection of CTX-M-28 in a Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain. Pathol Biol (Paris) 2009; 57: 343-8.
37. Ben Sallem R, Ben Slama K, Estepa V, Jouini A, Gharsa H, Klibi N, et al. Prevalence and characterisation of extendedspectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31: 1511-16.
38. Ben Slama K, Ben Sallem R, Jouini A, Rachid S, Moussa L, Saenz Y, et al. Diversity of genetic lineages among CTX-M-15 and CTX-M-14 producing Escherichia coli strains in a Tunisian hospital. Curr Microbiol 2011; 62: 1794-801.
39. Chouchani C, El Salabi A, Marrakchi R, Ferchichi L, Walsh TR. Characterization of IncA/C conjugative plasmid harboring bla TEM-52 and bla CTX-M-15 extended-spectrum betalactamases in clinical isolates of Escherichia coli in Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31: 1081-7.
40. Dahmen S, Bettaieb D, Mansour W, Boujaafar N, Bouallegue O, Arlet G. Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist 2010; 16: 163-70.
41. Dahmen S, Poirel L, Mansour W, Bouallegue O, Nordmann P. Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia. Clin Microbiol Infect 2010; 16: 1019-23.
42. Elhani D, Bakir L, Aouni M, Passet V, Arlet G, Brisse S, et al. Molecular epidemiology of extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin Microbiol Infect 2010; 16: 157-64.
43. Hammami S, Boutiba-Ben Boubaker I, Saidani M, Lakhal E, Ben Hassen A, Kamoun A, et al. Characterization and molecular epidemiology of extended spectrum beta-lactamase producing Enterobacter cloacae isolated from a Tunisian hospital. Microb Drug Resist 2012; 18: 59-65.
44. Lahlaoui H, Anis BH, Mohamed K, Mohamed BM. Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia. Microb Pathog 2012; 53: 64-5.
45. Lahlaoui H, Dahmen S, Moussa MB, Omrane B. First detection of TEM-116 extended-spectrum beta-lactamase in a Providencia stuartii isolate from a Tunisian hospital. Indian J Med Microbiol 2011; 29: 258-61.
46. Lahlaoui H, Poirel L, Barguellil F, Moussa MB, Nordmann P. Carbapenem-hydrolyzing class D beta-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia. Eur J Clin Microbiol Infect Dis 2012; 31: 937-9.
47. Lahlaoui H, Poirel L, Moussa MB, Ferjani M, Omrane B, Nordmann P. Nosocomial dissemination of extended-spectrum beta-lactamase VEB-1a-producing Providencia stuartii isolates in a Tunisian hospital. Eur J Clin Microbiol Infect Dis 2011; 30: 1267-70.
48. Mahrouki S, Ben-Achour N, Chouchani C, Ben-Moussa M, Belhadj O. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis. Pathol Biol (Paris) 2009; 57: e55-9.
49. Mahrouki S, Bourouis A, Chihi H, Ouertani R, Ferjani M, Moussa MB, et al. First characterisation of plasmid-mediated quinolone resistance-qnrS1 co-expressed bla CTX-M-15 and bla DHA-1 genes in clinical strain of Morganella morganii recovered from a Tunisian intensive care unit. Indian J Med Microbiol 2012; 30: 437-41.
50. Mnif B, Ktari S, Chaari A, Medhioub F, Rhimi F, Bouaziz M, et al. Nosocomial dissemination of Providencia stuartii isolates carrying bla OXA-48, bla PER-1, bla CMY-4 and qnrA6 in a Tunisian hospital. J Antimicrob Chemother 2013; 68: 329-32.
51. Rejiba S, Mercuri PS, Power P, Kechrid A. Emergence and dominance of CTX-M-15 extended spectrum beta-lactamase among Escherichia coli isolates from children. Microb Drug Resist 2011; 17: 135-40.
52. Beyene G, Nair S, Asrat D, Mengistu Y, Engers H, Wain J. Multidrug resistant Salmonella concord is a major cause of salmonellosis in children in Ethiopia. J Infect Dev Ctries 2011; 5: 23-33.
53. Kiiru J, Kariuki S, Goddeeris BM, Butaye P. Analysis of betalactamase phenotypes and carriage of selected beta-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period. BMC Microbiol 2012; 12: 155.
54. Boyle F, Healy G, Hale J, Kariuki S, Cormican M, Morris D. Characterization of a novel extended-spectrum beta-lactamase phenotype from OXA-1 expression in Salmonella typhimurium strains from Africa and Ireland. Diagn Microbiol Infect Dis 2011; 70: 549-53.
55. Muvunyi CM, Masaisa F, Bayingana C, Mutesa L, Musemakweri A, Muhirwa G, et al. Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines. Am J Trop Med Hyg 2011; 84: 923-8.
56. Mshana SE, Gerwing L, Minde M, Hain T, Domann E, Lyamuya E, et al. Outbreak of a novel Enterobacter sp. carrying blaCTX-M-15 in a neonatal unit of a tertiary care hospital in Tanzania. Int J Antimicrob Agents 2011; 38: 265-9.
57. Mshana SE, Imirzalioglu C, Hain T, Domann E, Lyamuya EF, Chakraborty T. Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin Microbiol Infect 2011; 17: 1279-82.
58. Lonchel CM, Meex C, Gangoue-Pieboji J, Boreux R, Assoumou MC, Melin P, et al. Proportion of extended-spectrum sslactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect Dis 2012; 12: 53.
59. Lonchel CM, Melin P, Gangoue-Pieboji J, Assoumou MC, Boreux R, De Mol P. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae in Cameroonian hospitals. Eur J Clin Microbiol Infect Dis 2013; 32: 79-87.
60. Bercion R, Mossoro-Kpinde D, Manirakiza A, Le Faou A. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. J Infect Dev Ctries 2009; 3: 187-90.
61. Feglo P, Adu-Sarkodie Y, Ayisi L, Jain R, Spurbeck RR, Springman AC, et al. Emergence of a novel extended-spectrumbeta-lactamase (ESBL)-producing, fluoroquinolone-resistant clone of extraintestinal pathogenic Escherichia coli in Kumasi, Ghana. J Clin Microbiol 2013; 51: 728-30.
62. Boisrame-Gastrin S, Tande D, Munck MR, Gouriou S, Nordmann P, Naas T. Salmonella carriage in adopted children from Mali: 2001-08. J Antimicrob Chemother 2011; 66: 2271-6.
63. Tande D, Boisrame-Gastrin S, Munck MR, Hery-Arnaud G, Gouriou S, Jallot N, et al. Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children. J Antimicrob Chemother 2010; 65: 859-65.
64. Tande D, Jallot N, Bougoudogo F, Montagnon T, Gouriou S, Sizun J. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Malian orphanage. Emerg Infect Dis 2009; 15: 472-4.
65. Woerther PL, Angebault C, Jacquier H, Hugede HC, Janssens AC, Sayadi S, et al. Massive increase, spread, and exchange of extended spectrum beta-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin Infect Dis 2011; 53: 677-85.
66. Aibinu I, Odugbemi T, Koenig W, Ghebremedhin B. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria. Clin Microbiol Infect 2012; 18: E49-51.
67. Iroha IR, Esimone CO, Neumann S, Marlinghaus L, Korte M, Szabados F, et al. First description of Escherichia coli producing CTX-M-15-extended spectrum beta lactamase (ESBL) in outpatients from south eastern Nigeria. Ann Clin Microbiol Antimicrob 2012; 11: 19.
68. Kasap M, Fashae K, Torol S, Kolayli F, Budak F, Vahaboglu H. Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria. Ann Clin Microbiol Antimicrob 2010; 9: 1.
69. Ogbolu DO, Daini OA, Ogunledun A, Alli AO, Webber MA. High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Int J Antimicrob Agents 2011; 37: 62-6.
70. Olowe OA, Grobbel M, Buchter B, Lubke-Becker A, Fruth A, Wieler LH. Detection of bla(CTX-M-15) extended-spectrum beta-lactamase genes in Escherichia coli from hospital patients in Nigeria. Int J Antimicrob Agents 2010; 35: 206-7.
71. Suh Yah C. Plasmid-encoded multidrug resistance: a case study of Salmonella and Shigella from enteric diarrhea sources among humans. Biol Res 2010; 43: 141-8.
72. Afunwa RA, Odimegwu DC, Iroha RI, Esimone CO. Antimicrobial resistance status and prevalence rates of extended spectrum beta-lactamase (ESBL) producers isolated from a mixed human population. Bosn J Basic Med Sci 2011; 11: 91-6.
73. Ruppe E, Woerther PL, Diop A, Sene AM, Da Costa A, Arlet G, et al. Carriage of CTX-M-15-producing Escherichia coli isolates among children living in a remote village in Senegal. Antimicrob Agents Chemother 2009; 53: 3135-7.
74. Brink AJ, Botha RF, Poswa X, Senekal M, Badal RE, Grolman DC, et al. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints. Surg Infect (Larchmt) 2012; 13: 43-9.
75. Cotton MF, Wasserman E, Smit J, Whitelaw A, Zar HJ. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect Dis 2008; 8: 40.
76. Ehlers MM, Veldsman C, Makgotlho EP, Dove MG, Hoosen AA, Kock MM. Detection of blaSHV, blaTEM and blaCTXM antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital. FEMS Immunol Med Microbiol 2009; 56: 191-6.
77. Habte TM, Dube S, Ismail N, Hoosen AA. Hospital and community isolates of uropathogens at a tertiary hospital in South Africa. S Afr Med J 2009; 99: 584-7.
78. Peirano G, van Greune CH, Pitout JD. Characteristics of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn Microbiol Infect Dis 2011; 69: 449-53.
79. Tau NP, Smith AM, Sooka A, Keddy KH. Molecular characterization of extended-spectrum beta-lactamase-producing Shigella isolates from humans in South Africa, 2003-2009. J Med Microbiol 2012; 61: 162-4.
80. Usha G, Chunderika M, Prashini M, Willem SA, Yusuf ES. Characterization of extended-spectrum beta-lactamases in Salmonella spp. at a tertiary hospital in Durban, South Africa. Diagn Microbiol Infect Dis 2008; 62: 86-91.